scholarly journals Ab initio prediction of mutation-induced cryptic splice-site activation and exon skipping

2009 ◽  
Vol 17 (6) ◽  
pp. 759-765 ◽  
Author(s):  
Petr Divina ◽  
Andrea Kvitkovicova ◽  
Emanuele Buratti ◽  
Igor Vorechovsky
2006 ◽  
Vol 96 (12) ◽  
pp. 711-716 ◽  
Author(s):  
Lisa Gallinaro ◽  
Francesca Sartorello ◽  
Elena Pontara ◽  
Maria Cattini ◽  
Antonella Bertomoro ◽  
...  

SummaryWe describe the complex picture associated with a mutated splice junction in intron 13 of von Willebrand factor (VWF) gene. The proband, characterized by a marked decrease in plasma and platelet VWF and near normal multimer organization, was classified as recessive type 1 von Willebrand disease (VWD). Genetic analysis demonstrated that he was homozygous for the 1534–3C>A mutation in the consensus sequence of the acceptor splicing site of intron 13 of the VWF gene. Platelet mRNA analysis documented three VWF transcripts: a wild type generated by the correct recognition of the mutated splice site, a smaller transcript not containing exon 14, and a longer one that, in addition to exons 13 and 14, included a 62bp fragment corresponding to the end of intron 13. The small transcript derives from the skipping of exon 14, the long one from the activation of a cryptic splice site in intron 13; both show a premature stop codon inVWF propeptide, so the probandVWF derives entirely from the correct splice site recognition. Combined incomplete exon skipping and cryptic splice site activation are first recognized in VWD. Since the 1534–3C>A mutation does not abolish the normal processing of mRNA, it is unlikely to be found in type 3VWD. This mutation therefore appears to be peculiar to type 1 VWD.


2020 ◽  
Author(s):  
Diana Alexieva ◽  
Yi Long ◽  
Rupa Sarkar ◽  
Hansraj Dhayan ◽  
Emmanuel Bruet ◽  
...  

Abstract We report that low level background splicing by normal genes can be used to predict the likely effect of splicing mutations upon cryptic splice site activation and exon skipping, with emphasis on the DBASS databases, BRCA1, BRCA2 and DMD. In addition we show that background RNA splice sites are also involved in pseudoexon formation, recursive splicing and aberrant splicing in cancer. We discuss how background splicing information might inform splicing therapy.


2021 ◽  
Vol 125 (7) ◽  
pp. 4267-4276
Author(s):  
William Lafargue-Dit-Hauret ◽  
Camille Latouche ◽  
Stéphane Jobic

2002 ◽  
Vol 47 (12) ◽  
pp. 0665-0676 ◽  
Author(s):  
D. M. Dunn ◽  
T. Ishigami ◽  
J. Pankow ◽  
A. von Niederhausern ◽  
J. Alder ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document